Mumbai redevelopment news: The company wants to explore projects in the old building and society redevelopment segment in the Mumbai Metropolitan Region (MMR). It has no plans to bid for slum rehabilitation projects or other segments such as warehousing and logistics.

Read More

​ Mumbai redevelopment news: The company wants to explore projects in the old building and society redevelopment segment in the Mumbai Metropolitan Region (MMR). It has no plans to bid for slum rehabilitation projects or other segments such as warehousing and logistics. Mumbai redevelopment news: The company wants to explore projects in the old building and society redevelopment segment in the Mumbai Metropolitan Region (MMR). It has no plans to bid for slum rehabilitation projects or other segments such as warehousing and logistics.  Moneycontrol Latest News Read More  

Mumbai redevelopment news: The company wants to explore projects in the old building and society redevelopment segment in the Mumbai Metropolitan Region (MMR). It has no plans to bid for slum rehabilitation projects or other segments such as warehousing and logistics.

Units engaged in oursourced work of overseas clients are referred as CIHs (capabilities and innovation hubs).

Read More

​ Units engaged in oursourced work of overseas clients are referred as CIHs (capabilities and innovation hubs). Units engaged in oursourced work of overseas clients are referred as CIHs (capabilities and innovation hubs).  Moneycontrol Latest News Read More  

Units engaged in oursourced work of overseas clients are referred as CIHs (capabilities and innovation hubs).

Gross domestic product fell 0.3% following a gain of 0.2% in September, the Office for National Statistics said Wednesday. The drop was the first since July and exceeded the 0.1% fall economists had forecast.

Read More

​ Gross domestic product fell 0.3% following a gain of 0.2% in September, the Office for National Statistics said Wednesday. The drop was the first since July and exceeded the 0.1% fall economists had forecast. Gross domestic product fell 0.3% following a gain of 0.2% in September, the Office for National Statistics said Wednesday. The drop was the first since July and exceeded the 0.1% fall economists had forecast.  Moneycontrol Latest News Read More  

Gross domestic product fell 0.3% following a gain of 0.2% in September, the Office for National Statistics said Wednesday. The drop was the first since July and exceeded the 0.1% fall economists had forecast.

Shares of the chemical manufacturer have fallen sharply in recent days after Rainbow Agro entered the pyroxasulfone market with a substantial 2,000-tonne project approval

Read More

​ Shares of the chemical manufacturer have fallen sharply in recent days after Rainbow Agro entered the pyroxasulfone market with a substantial 2,000-tonne project approval Shares of the chemical manufacturer have fallen sharply in recent days after Rainbow Agro entered the pyroxasulfone market with a substantial 2,000-tonne project approval  Moneycontrol Latest News Read More  

Shares of the chemical manufacturer have fallen sharply in recent days after Rainbow Agro entered the pyroxasulfone market with a substantial 2,000-tonne project approval

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

Read More

​ ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023. ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.  Moneycontrol Latest News Read More  

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

Read More

​ ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023. ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.  Moneycontrol Latest News Read More  

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

Read More

​ ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023. ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.  Moneycontrol Latest News Read More  

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

Read More

​ ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023. ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.  Moneycontrol Latest News Read More  

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

In a statement, the bank said the lender will shortly integrate its system with the railways ministry to operationalise the pension disbursement process.

Read More

​ In a statement, the bank said the lender will shortly integrate its system with the railways ministry to operationalise the pension disbursement process. In a statement, the bank said the lender will shortly integrate its system with the railways ministry to operationalise the pension disbursement process.  Moneycontrol Latest News Read More  

In a statement, the bank said the lender will shortly integrate its system with the railways ministry to operationalise the pension disbursement process.

Ilumetri is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Read More

​ Ilumetri is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Ilumetri is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.  Moneycontrol Latest News Read More  

Ilumetri is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.